BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fujiwara K, Tanaka Y, Orito E, Ohno T, Kato T, Sugauchi F, Suzuki S, Hattori Y, Sakurai M, Hasegawa I, Ozasa T, Kanie F, Kano H, Ueda R, Mizokami M. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease. J Gastroenterol Hepatol 2004;19:1343-7. [DOI: 10.1111/j.1440-1746.2004.03439.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Kannangai R, Vivekanandan P, Netski D, Mehta S, Kirk GD, Thomas DL, Torbenson M. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. J Clin Virol. 2007;39:101-105. [PMID: 17452002 DOI: 10.1016/j.jcv.2007.03.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
2 Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. J Med Virol. 2007;79:1464-1471. [PMID: 17705185 DOI: 10.1002/jmv.20954] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
3 Marque-juillet S, Benghalia K, Monnier S, Fernand-laurent C, Mazeron M, Harzic M. Faut-il rechercher une hépatite B occulte chez les patients infectés par le virus de l’immunodéficience humaine (VIH) ? Pathologie Biologie 2010;58:e39-42. [DOI: 10.1016/j.patbio.2009.07.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Fujiwara K, Tanaka Y, Paulon E, Orito E, Sugiyama M, Ito K, Ueda R, Mizokami M, Naoumov NV. Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E. J Virol. 2005;79:14404-14410. [PMID: 16254374 DOI: 10.1128/jvi.79.22.14404-14410.2005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
5 Covolo L, Pollicino T, Raimondo G, Donato F. Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis. Dig Liver Dis. 2013;45:238-244. [PMID: 23146778 DOI: 10.1016/j.dld.2012.09.021] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
6 Selim HS, Abou-donia HA, Taha HA, El Azab GI, Bakry AF. Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes. European Journal of Internal Medicine 2011;22:187-90. [DOI: 10.1016/j.ejim.2010.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
7 Lin L, Verslype C, van Pelt JF, van Ranst M, Fevery J. Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses. Eur J Gastroenterol Hepatol 2006;18:1311-9. [PMID: 17099381 DOI: 10.1097/01.meg.0000243881.09820.09] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
8 Mina P, Georgiadou SP, Rizos C, Dalekos GN, Rigopoulou EI. Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol 2010; 16(2): 225-231 [PMID: 20066742 DOI: 10.3748/wjg.v16.i2.225] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
9 Mahmoud OAEK, Ghazal AAER, Metwally DES, Shamseya MM, Hamdallah HM. Detection of occult hepatitis B virus among chronic hepatitis C patients. Alexandria Journal of Medicine 2016;52:115-23. [DOI: 10.1016/j.ajme.2015.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Rodríguez-torres M, Gonzalez-garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-correa M, Depamphilis J, Torriani F; for the APRICOT investigators. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: Clinically relevant or a diagnostic problem? J Med Virol 2007;79:694-700. [DOI: 10.1002/jmv.20836] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
11 Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dalekos GN. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver International 2009;29:434-42. [DOI: 10.1111/j.1478-3231.2008.01851.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
12 El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, Abdel-Sattar RM, Ahmady AM, El-Nakeeb A. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008;18:55-61. [PMID: 18279193 DOI: 10.1111/j.1365-3148.2007.00806.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]